CECOG Academy Podcasts: Recent Episodes
CECOG - Central European Cooperative Oncology Group
CECOG has been formed to further the performance of clinical trials according to highest standards and to foster medical education in the area of oncology to the benefit for cancer patients in Central and Southeastern Europe and beyond.
Knowledge of genetics required by healthcare professionals prior to mainstream consenting
**Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment
Host: Doz. Dr. Christiane Thallinger**
Univ. Prof. Dr. Evandro De Azambuja
Institut Jules Bordet
Belgium
Univ. Prof. Dr. Christoph Zielinski
Professor of Medical Oncology and Clinical Immunology
Medical Director, Wiener Privatklinik and Central European Cancer Center
Wien, Austria
President, Central European Cooperative Oncology Group (CECOG)
Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021
**Targeted treatment options to improve outcomes in EGFRm NSCLC
Host: Doz. Dr. Christiane Thallinger
Univ. Prof Dr. Martin Filipits**
Institute of Cancer Research
Department of Medicine I
Medical University of Vienna
Univ. Prof. Dr Bojan Zaric
Institute for Pulmonary Diseases of Vojvodina
Faculty of Medicine
University of Novi Sad, Serbia
**Clinical implementation of immuno-oncology therapy in unresectable stage III NSCLC
Host: Doz. Dr. Christiane Thallinger
Univ. Prof.Dr. Tanja Cufer**
University Clinic Golnik
Medical Faculty Ljubljana
Slovenia
Univ. Prof. Dr. Rafal Dziadziusko
Department of Oncology and Radiotherapy
Medical University of Gdansk
How new treatments are impacting the work of Multidisciplinary Teams (MTD) (incl guidelines discussion)
Host: Doz. Dr. Christiane Thallinger
Speakers:
Dr. Mila Petrova
MHAT Nadezhda
Sofia, Bulgaria
Univ. Prof. Dr. Christoph Zielinski
Professor of Medical Oncology and Clinical Immunology
Medical Director, Wiener Privatklinik and Central European Cancer Center
Wien, Austria
President, Central European Cooperative Oncology Group (CECOG)
Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021
Changing the ES-SCLC Paradigm with Immuno-Oncology Combinations
Host: Doz. Dr. Christiane Thallinger
Speakers:
Univ. Prof. Dr. Marko Jakopovic
Thoracic Oncology Unit
Department for Respiratory Diseases
University Hospital Centre Zagreb, Croatia
Univ Prof Dr. Wolfgang Köstler
Department of Medicine I,
Clinical Division of Oncology,
Medical University of Vienna, Austria
**Patient needs in later lines of mBC (testing, efficacy of current treatment – what do we need)
Host: Doz. Dr. Christiane Thallinger
Univ. Prof. Dr. Rupert Bartsch**
Department of Medicine I,
Clinical Division of Oncology,
Medical University of Vienna, Austria
Dr. Alexandru Eniu, MD, PhD
HÔPITAL RIVIERA-CHABLAIS, VAUD-VALAIS,
Spécialiste FMH en oncologie médicale
Médecin chef - Responsable Breast Unit
Switzerland
CECOG Offers TIGER and LEOPARD Virtual Transborder Tumour Boards to Deliver Optimal Cancer Care and Precision Medicine.
In this podcast, the president of CECGO, Prof. Christoph Zielinski, describes the problems and shortcomings of cancer care in Central and Southeastern Europe, as compared to the Western part of the contiinent and describes ways to overcome the deficits by reduction of systemic health inequalities and improvement of access to cancer care by focussing on prevention, screening, early diagnosis, and access to state of the art cancer diagnosis and treatment. The Dashboard which has been developed together with key opnion leaders including oncolocgists, patient advocates, representatives of policy making bodies and reimbursement agencies calls for very defined endpoints which would result in an amelioration of the spent financial means, but - importantly - to a reduction in mortality from cancer in the region by 50% until 2030.